Viloxazine
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 432 publications
Benefits and harms of ADHD interventions: umbrella review and platform for shared decision making.
Journal: BMJ (Clinical research ed.)
Published: November 26, 2025
Updated Viloxazine Pharmacology: Experiments Establish Norepinephrine Transporter Occupancy and Serotonin 5-HT2C, 5-HT2B, and 5-HT7 Receptor Binding at Therapeutically Relevant Concentrations.
Journal: Drugs in R&D
Published: October 29, 2025
Connecting the dots and finding the way forward: Pharmacological, neuromodulatory, and psychotherapeutic interventions for the complex treatment of adult ADHD.
Journal: Pharmacology & therapeutics
Published: October 06, 2025
Potential treatments for attention-deficit/hyperactivity disorder: a focus on Phase III trials.
Journal: Expert opinion on pharmacotherapy
Published: September 23, 2025
The Viloxazine Paradox: A Noradrenergic Agent's Journey From Antidepressant Obscurity to ADHD Precision Therapy.
Journal: CNS neuroscience & therapeutics
Published: August 17, 2025
Viloxazine Extended-Release: A Review in Attention-Deficit/Hyperactivity Disorder in Adults.
Journal: CNS drugs
Published: June 02, 2025
Cognitive Impairment in Adult Attention Deficit Hyperactivity Disorder: Clinical Implications and Novel Treatment Strategies.
Journal: Clinics and practice
Published: May 24, 2025
Comparative Effectiveness of Pharmacological and Non-pharmacological Therapies for ADHD: A Systematic Review and Meta-analysis of Randomized Controlled Trials (2008-2023).
Journal: Reviews on recent clinical trials
Published: April 29, 2025
Last Updated: 04/28/2026